MedPath

PIASKY

PIASKY

Approved
DIN Number

02558262

Drug Class

Human

Market Date

N/A

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02558262
AIG Number0166965001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AJ07 CROVALIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous
AHFS Classification90:20.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CROVALIMABActive
Strength: 170 MG / ML
Monograph: CROVALIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.